Endoscopy December 2018 PMID 29883979

Dilation or biodegradable stent placement for recurrent benign esophageal strictures: a randomized controlled trial.

Daisy Walter, Maarten W van den Berg, Meike M Hirdes, Frank P Vleggaar, Alessandro Repici, Pierre H Deprez, Bartolomé L Viedma, Laurence B Lovat, Bas L Weusten, Raf Bisschops, Rehan Haidry, Elisa Ferrara, Keith J Sanborn, Erin E O'Leary, Jeanin E van Hooft

Full text PDF Download social card

Mentions

Peak: 1 in Nov 2018

across 3 sources since Nov 2018

Extended reach

2,822

potential audience

Total likes

Video views

308

Mentions per month

Nov 2018 – Jun 2019

Where it's discussed

Facebook2 posts
X / Twitter1 posts
YouTube1 videos

AI synopsis

What people are saying

Discussions highlight the promising findings that biodegradable stents may reduce early recurrence of strictures, with phrases like 'significant reduction' and 'potential game changer,' but also mention that further research is needed, showing an optimistic yet cautious tone that balances interest with scientific skepticism.

AgreementModerate agreement

Most discussions acknowledge the positive aspects of the study, such as reduced need for repeat procedures with biodegradable stents.

InterestModerate interest

Participants show moderate interest, often commenting on potential clinical benefits and safety but not delving deeply into technical details.

EngagementModerate engagement

Comments include curiosity about long-term outcomes and calls for more research, indicating a reasonable level of engagement.

ImpactModerate impact

The discussions suggest that the study could influence clinical practices and future research directions, reflecting a moderate impact.

Abstract in brief

This study compares the effectiveness of biodegradable stents versus traditional dilation for treating recurrent benign esophageal strictures (BES), finding that biodegradable stents reduce the number of repeat dilations and prolong time to recurrence in the early months.
At 3 months, patients with biodegradable stents needed significantly fewer follow-up dilations compared to those with just dilation, though this difference was not observed by 6 months, and safety profiles were similar with some serious adverse events.
Patients with biodegradable stents showed improved activity levels over 12 months and longer intervals before needing further treatment, but the study highlights the need for more research to determine their exact role in managing BES.

Read the full abstract

All mentions

Biodegradable Stents versus Dilation for Recurrent Esophageal Strictures

This study compares biodegradable stents and traditional dilation for recurrent benign esophageal strictures, showing that stents reduce early repeat dilations and extend time to recurrence, with similar safety profiles.

endoscopythieme · Nov 28, 2018 308 views

UCL Discovery

@ucl_discovery · X

Open Access UCL Research: Dilation or biodegradable stent placement for recurrent benign esophageal strictures: a randomized controlled trial https://t.co/5zGdanBvxz

Jun 21, 2019 · 2,515 followers View post →